CN Stock MarketDetailed Quotes

002275 Guilin Sanjin Pharmaceutical

Watchlist

14.79
+0.03+0.20%

Trading Nov 28 10:37 CST

8.69BMarket Cap21.28P/E (TTM)

Guilin Sanjin Pharmaceutical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Assets

Current assets

Money funds

-5.45%1.18B

-7.19%1.21B

-31.68%932.85M

-16.40%1.06B

-17.01%1.24B

-21.54%1.3B

-14.70%1.37B

-14.34%1.27B

-13.36%1.5B

2.25%1.66B

Transactional financial assets

16.38%241.09M

36.44%183.54M

157.78%389.55M

88.97%304.69M

324.05%207.16M

285.98%134.53M

-33.09%151.12M

-27.29%161.24M

388.53%48.85M

-41.91%34.85M

Notes receivable and accounts receivable

-23.89%187.04M

-20.07%206.22M

51.03%208.76M

9.61%79.1M

206.76%245.76M

31.52%257.99M

84.26%138.23M

51.86%72.17M

32.86%80.11M

113.93%196.16M

-Accounts receivable

-23.89%187.04M

-20.07%206.22M

51.03%208.76M

9.61%79.1M

206.76%245.76M

31.52%257.99M

84.26%138.23M

51.86%72.17M

32.86%80.11M

113.93%196.16M

Other receivables (including interest and dividends)

-23.37%38.82M

-77.61%7.44M

-33.28%16.72M

-92.37%4.39M

50.77%50.66M

-58.12%33.26M

17.74%25.06M

532.72%57.58M

33.35%33.6M

60.55%79.41M

-Other receivable

----

-77.61%7.44M

----

-58.12%33.26M

----

532.72%57.58M

----

60.55%79.41M

Advance payment

110.96%71.82M

45.74%67.33M

30.15%38.85M

-6.62%19.58M

-55.45%34.04M

6.62%46.2M

-34.24%29.85M

-15.95%20.96M

66.05%76.42M

55.52%43.33M

Inventories

2.05%256.29M

-4.22%253.58M

17.85%270.37M

4.52%255.96M

-8.95%251.15M

1.63%264.76M

-23.40%229.43M

-13.82%244.9M

56.20%275.84M

43.76%260.52M

Receivable financing

13.48%251.7M

19.13%164.08M

-59.82%215.99M

-19.37%379.23M

-38.76%221.81M

-27.79%137.74M

91.76%537.56M

28.68%470.34M

21.50%362.22M

-6.31%190.75M

Assets held for sale

--33.02M

----

Other current assets

59.93%9.98M

83.25%10.5M

-45.10%7.42M

1,413.93%61.98M

-82.71%6.24M

-80.08%5.73M

-40.28%13.51M

-82.55%4.09M

-7.26%36.1M

-13.97%28.77M

Total current assets

0.23%2.27B

-2.21%2.14B

-15.12%2.11B

-4.39%2.2B

-6.28%2.26B

-12.48%2.18B

-3.13%2.49B

-6.40%2.3B

1.12%2.41B

9.82%2.49B

Non Current assets

Other equity investment

-22.42%81.19M

-31.97%81.87M

-34.85%84.55M

-28.69%93.92M

44.79%104.67M

3,543.76%120.35M

3,828.84%129.77M

3,887.59%131.71M

2,088.68%72.29M

0.00%3.3M

Investment real estate

----

40.51%6.56K

-45.57%20.04K

Long-term equity investment

195.19%10.36M

-1.00%4.86M

8.18%5.31M

314.81%3.77M

287.59%3.51M

442.01%4.91M

0.34%908.72K

0.48%905.65K

0.47%905.65K

Fixed assets

----

-1.52%1.02B

----

-4.20%1.03B

----

-3.06%1.08B

----

7.84%1.08B

Constru in process

----

-24.83%42.97M

----

-45.37%57.17M

----

-41.42%61.66M

----

-65.67%104.65M

Intangible assets

-11.66%143.36M

-11.90%144.91M

-11.54%147.11M

-8.75%153.56M

-5.68%162.28M

-5.31%164.49M

-5.46%166.3M

-5.66%168.28M

4.24%172.06M

6.09%173.71M

Goodwill

0.00%5.7M

Long deferred expense

-6.54%111.28M

-6.25%113.57M

-6.06%115.81M

-6.93%117.04M

-3.55%119.06M

-3.11%121.15M

-3.03%123.28M

-2.36%125.76M

1,496.45%123.44M

1,452.01%125.04M

Deferred tax assets

13.23%9.34M

13.27%9.34M

9.40%9.33M

-27.31%8.25M

-27.35%8.25M

-24.87%8.53M

24.25%11.35M

20.07%11.35M

Usufruct assets

-35.55%47.95M

-34.59%51.59M

-41.97%49.84M

-19.50%71.05M

-13.64%74.39M

-5.74%78.86M

-7.80%85.88M

-8.95%88.27M

-31.59%86.15M

-35.88%83.66M

Other non current assets

--201.4M

----

Total non current assets

6.45%1.67B

5.00%1.67B

3.76%1.69B

4.32%1.74B

-4.09%1.57B

0.46%1.59B

1.24%1.63B

1.60%1.67B

-0.09%1.63B

-2.93%1.59B

Total assets

2.77%3.93B

0.83%3.81B

-7.65%3.81B

-0.73%3.94B

-5.39%3.83B

-7.45%3.78B

-1.45%4.12B

-3.20%3.96B

0.63%4.05B

4.49%4.08B

Liabilities

Current liabilities

Short term loan

-4.19%233.98M

-0.09%213.98M

-42.34%163.7M

95.84%274.2M

0.83%244.22M

-24.03%214.18M

12.77%283.9M

-44.37%140.01M

58.55%242.2M

84.20%281.92M

Notes payable and accounts payable

-34.12%30.17M

-11.54%41.98M

50.57%105.47M

50.38%201.38M

-65.00%45.8M

-55.89%47.46M

-59.39%70.04M

-25.70%133.92M

35.48%130.84M

-6.00%107.59M

-Notes payable

-42.23%1.3M

-28.63%1.55M

9.98%3.02M

--1.19M

-91.49%2.24M

-80.16%2.17M

-82.94%2.75M

----

12.65%26.37M

-76.82%10.92M

-Accounts payable

-33.70%28.87M

-10.72%40.44M

52.23%102.45M

49.49%200.19M

-58.31%43.55M

-53.15%45.29M

-56.96%67.3M

-16.18%133.92M

42.79%104.47M

43.57%96.67M

Contract liabilities

43.08%19.37M

65.32%17.14M

-32.60%14.7M

-55.30%75.99M

7.28%13.54M

38.86%10.37M

-39.39%21.81M

28.03%170.01M

-83.68%12.62M

-59.35%7.46M

Salaries payable

20.42%15.06M

1.65%12.58M

-0.95%11.67M

-18.71%35.62M

7.58%12.51M

19.95%12.37M

9.86%11.78M

35.79%43.81M

266.08%11.62M

17.60%10.32M

Taxs payable

36.61%57.98M

161.36%51.11M

-79.18%24.83M

-50.25%46.34M

-49.70%42.44M

-78.65%19.56M

51.47%119.25M

97.07%93.16M

98.16%84.39M

99.08%91.6M

Other payable (including interest and dividends)

23.02%201.05M

56.23%189.06M

15.56%229.54M

5.19%131.47M

-22.03%163.43M

-50.80%121.02M

3.02%198.64M

-0.51%124.98M

50.84%209.6M

127.24%245.95M

-Dividend payable

----

--29.3M

-Other payable

----

56.23%189.06M

----

-44.14%121.02M

----

22.32%124.98M

----

100.17%216.65M

Non current liabilities due within one year

187.67%36.96M

367.16%117.68M

234.42%113.6M

-0.11%119.26M

-91.24%12.85M

-71.83%25.19M

-37.17%33.97M

180.55%119.39M

181.41%146.69M

208.13%89.43M

Other current liabilities

27.91%1.25M

37.66%1M

28.51%1.43M

-55.81%9.57M

-82.32%976.08K

-86.82%727.57K

-85.49%1.11M

28.92%21.66M

--5.52M

2,502.13%5.52M

Total current liabilities

11.21%595.82M

42.95%644.53M

-10.21%664.93M

5.54%893.83M

-36.48%535.76M

-46.31%450.87M

-7.92%740.51M

2.14%846.94M

49.68%843.49M

75.65%839.78M

Current liabilities

Long term loan

23.10%199.46M

-44.85%107.86M

-54.36%98.63M

-42.26%73.92M

66.78%162.04M

10.91%195.58M

0.95%216.11M

-43.58%128.03M

-57.29%97.16M

-31.65%176.34M

Estimate liabilities

--1.34M

----

Deferred tax liabilities

----

-93.47%46.76K

-93.72%46.05K

-54.90%330.64K

24.35%716.17K

Long term deferred income

-6.21%78.65M

-17.62%74.38M

-5.85%86.8M

-9.00%89.04M

-14.02%83.85M

-12.03%90.29M

-15.43%92.2M

-12.03%97.85M

-20.95%97.53M

-4.84%102.65M

Lease liabilities

-37.89%44.9M

-35.54%47.21M

-41.53%46.9M

-22.31%60.95M

-6.04%72.29M

-5.88%73.24M

-7.46%80.21M

-10.78%78.45M

-9.45%76.94M

-9.37%77.81M

Total non current liabilities

1.92%324.34M

-35.74%230.79M

-39.86%233.67M

-26.06%225.25M

16.85%318.23M

0.46%359.16M

-5.35%388.57M

-28.62%304.66M

-37.59%272.34M

-20.96%357.51M

Total liabilities

7.75%920.16M

8.06%875.31M

-20.41%898.6M

-2.82%1.12B

-23.47%853.98M

-32.35%810.02M

-7.05%1.13B

-8.32%1.15B

11.59%1.12B

28.68%1.2B

Shareholders equity

Paid-in capital

0.00%587.57M

-0.45%587.57M

0.00%590.2M

Capital reserve funds

1.37%672.09M

2.34%672.09M

2.87%669.24M

4.77%669.24M

6.93%662.99M

3.49%656.75M

5.57%650.57M

-7.46%638.76M

-10.17%620.03M

-8.07%634.58M

Surplus reserve funds

0.00%325.5M

Retained profit

3.96%1.47B

-0.70%1.38B

-4.18%1.36B

0.80%1.26B

-4.28%1.41B

-4.06%1.39B

-9.18%1.42B

-13.48%1.25B

-9.17%1.47B

-7.90%1.45B

Less:Treasury stock

----

-58.77%84.1M

-41.17%120.02M

Other composite income

-221.62%-36.04M

-814.21%-34.56M

-362.31%-31.99M

-260.71%-22.72M

-221.92%-11.21M

118.59%4.84M

382.04%12.19M

469.18%14.13M

595.78%9.19M

195.86%2.21M

Shareholders equity without minority interests

1.35%3.01B

-1.14%2.93B

-2.83%2.91B

0.13%2.82B

1.49%2.97B

2.89%2.97B

0.85%2.99B

-0.93%2.81B

-3.00%2.93B

-3.08%2.88B

Total shareholder equity

1.35%3.01B

-1.14%2.93B

-2.83%2.91B

0.13%2.82B

1.49%2.97B

2.89%2.97B

0.85%2.99B

-0.93%2.81B

-3.00%2.93B

-3.08%2.88B

Total liabilityies and equity

2.77%3.93B

0.83%3.81B

-7.65%3.81B

-0.73%3.94B

-5.39%3.83B

-7.45%3.78B

-1.45%4.12B

-3.20%3.96B

0.63%4.05B

4.49%4.08B

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Tianjian Certified Public Accountants (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Assets
Current assets
Money funds	-5.45%1.18B	-7.19%1.21B	-31.68%932.85M	-16.40%1.06B	-17.01%1.24B	-21.54%1.3B	-14.70%1.37B	-14.34%1.27B	-13.36%1.5B	2.25%1.66B
Transactional financial assets	16.38%241.09M	36.44%183.54M	157.78%389.55M	88.97%304.69M	324.05%207.16M	285.98%134.53M	-33.09%151.12M	-27.29%161.24M	388.53%48.85M	-41.91%34.85M
Notes receivable and accounts receivable	-23.89%187.04M	-20.07%206.22M	51.03%208.76M	9.61%79.1M	206.76%245.76M	31.52%257.99M	84.26%138.23M	51.86%72.17M	32.86%80.11M	113.93%196.16M
-Accounts receivable	-23.89%187.04M	-20.07%206.22M	51.03%208.76M	9.61%79.1M	206.76%245.76M	31.52%257.99M	84.26%138.23M	51.86%72.17M	32.86%80.11M	113.93%196.16M
Other receivables (including interest and dividends)	-23.37%38.82M	-77.61%7.44M	-33.28%16.72M	-92.37%4.39M	50.77%50.66M	-58.12%33.26M	17.74%25.06M	532.72%57.58M	33.35%33.6M	60.55%79.41M
-Other receivable	----	-77.61%7.44M	----	----	----	-58.12%33.26M	----	532.72%57.58M	----	60.55%79.41M
Advance payment	110.96%71.82M	45.74%67.33M	30.15%38.85M	-6.62%19.58M	-55.45%34.04M	6.62%46.2M	-34.24%29.85M	-15.95%20.96M	66.05%76.42M	55.52%43.33M
Inventories	2.05%256.29M	-4.22%253.58M	17.85%270.37M	4.52%255.96M	-8.95%251.15M	1.63%264.76M	-23.40%229.43M	-13.82%244.9M	56.20%275.84M	43.76%260.52M
Receivable financing	13.48%251.7M	19.13%164.08M	-59.82%215.99M	-19.37%379.23M	-38.76%221.81M	-27.79%137.74M	91.76%537.56M	28.68%470.34M	21.50%362.22M	-6.31%190.75M
Assets held for sale	--33.02M	--33.02M	--33.02M	--33.02M	----	----	----	----	----	----
Other current assets	59.93%9.98M	83.25%10.5M	-45.10%7.42M	1,413.93%61.98M	-82.71%6.24M	-80.08%5.73M	-40.28%13.51M	-82.55%4.09M	-7.26%36.1M	-13.97%28.77M
Total current assets	0.23%2.27B	-2.21%2.14B	-15.12%2.11B	-4.39%2.2B	-6.28%2.26B	-12.48%2.18B	-3.13%2.49B	-6.40%2.3B	1.12%2.41B	9.82%2.49B
Non Current assets
Other equity investment	-22.42%81.19M	-31.97%81.87M	-34.85%84.55M	-28.69%93.92M	44.79%104.67M	3,543.76%120.35M	3,828.84%129.77M	3,887.59%131.71M	2,088.68%72.29M	0.00%3.3M
Investment real estate	----	----	----	----	----	----	----	----	40.51%6.56K	-45.57%20.04K
Long-term equity investment	195.19%10.36M	-1.00%4.86M	8.18%5.31M	314.81%3.77M	287.59%3.51M	442.01%4.91M	442.01%4.91M	0.34%908.72K	0.48%905.65K	0.47%905.65K
Fixed assets	----	-1.52%1.02B	----	----	----	-4.20%1.03B	----	-3.06%1.08B	----	7.84%1.08B
Constru in process	----	-24.83%42.97M	----	----	----	-45.37%57.17M	----	-41.42%61.66M	----	-65.67%104.65M
Intangible assets	-11.66%143.36M	-11.90%144.91M	-11.54%147.11M	-8.75%153.56M	-5.68%162.28M	-5.31%164.49M	-5.46%166.3M	-5.66%168.28M	4.24%172.06M	6.09%173.71M
Goodwill	0.00%5.7M	0.00%5.7M	0.00%5.7M	0.00%5.7M	0.00%5.7M	0.00%5.7M	0.00%5.7M	0.00%5.7M	0.00%5.7M	0.00%5.7M
Long deferred expense	-6.54%111.28M	-6.25%113.57M	-6.06%115.81M	-6.93%117.04M	-3.55%119.06M	-3.11%121.15M	-3.03%123.28M	-2.36%125.76M	1,496.45%123.44M	1,452.01%125.04M
Deferred tax assets	13.23%9.34M	13.23%9.34M	13.27%9.34M	9.40%9.33M	-27.31%8.25M	-27.31%8.25M	-27.35%8.25M	-24.87%8.53M	24.25%11.35M	20.07%11.35M
Usufruct assets	-35.55%47.95M	-34.59%51.59M	-41.97%49.84M	-19.50%71.05M	-13.64%74.39M	-5.74%78.86M	-7.80%85.88M	-8.95%88.27M	-31.59%86.15M	-35.88%83.66M
Other non current assets	--201.4M	--201.4M	--201.4M	--201.4M	----	----	----	----	----	----
Total non current assets	6.45%1.67B	5.00%1.67B	3.76%1.69B	4.32%1.74B	-4.09%1.57B	0.46%1.59B	1.24%1.63B	1.60%1.67B	-0.09%1.63B	-2.93%1.59B
Total assets	2.77%3.93B	0.83%3.81B	-7.65%3.81B	-0.73%3.94B	-5.39%3.83B	-7.45%3.78B	-1.45%4.12B	-3.20%3.96B	0.63%4.05B	4.49%4.08B
Liabilities
Current liabilities
Short term loan	-4.19%233.98M	-0.09%213.98M	-42.34%163.7M	95.84%274.2M	0.83%244.22M	-24.03%214.18M	12.77%283.9M	-44.37%140.01M	58.55%242.2M	84.20%281.92M
Notes payable and accounts payable	-34.12%30.17M	-11.54%41.98M	50.57%105.47M	50.38%201.38M	-65.00%45.8M	-55.89%47.46M	-59.39%70.04M	-25.70%133.92M	35.48%130.84M	-6.00%107.59M
-Notes payable	-42.23%1.3M	-28.63%1.55M	9.98%3.02M	--1.19M	-91.49%2.24M	-80.16%2.17M	-82.94%2.75M	----	12.65%26.37M	-76.82%10.92M
-Accounts payable	-33.70%28.87M	-10.72%40.44M	52.23%102.45M	49.49%200.19M	-58.31%43.55M	-53.15%45.29M	-56.96%67.3M	-16.18%133.92M	42.79%104.47M	43.57%96.67M
Contract liabilities	43.08%19.37M	65.32%17.14M	-32.60%14.7M	-55.30%75.99M	7.28%13.54M	38.86%10.37M	-39.39%21.81M	28.03%170.01M	-83.68%12.62M	-59.35%7.46M
Salaries payable	20.42%15.06M	1.65%12.58M	-0.95%11.67M	-18.71%35.62M	7.58%12.51M	19.95%12.37M	9.86%11.78M	35.79%43.81M	266.08%11.62M	17.60%10.32M
Taxs payable	36.61%57.98M	161.36%51.11M	-79.18%24.83M	-50.25%46.34M	-49.70%42.44M	-78.65%19.56M	51.47%119.25M	97.07%93.16M	98.16%84.39M	99.08%91.6M
Other payable (including interest and dividends)	23.02%201.05M	56.23%189.06M	15.56%229.54M	5.19%131.47M	-22.03%163.43M	-50.80%121.02M	3.02%198.64M	-0.51%124.98M	50.84%209.6M	127.24%245.95M
-Dividend payable	----	----	----	----	----	----	----	----	----	--29.3M
-Other payable	----	56.23%189.06M	----	----	----	-44.14%121.02M	----	22.32%124.98M	----	100.17%216.65M
Non current liabilities due within one year	187.67%36.96M	367.16%117.68M	234.42%113.6M	-0.11%119.26M	-91.24%12.85M	-71.83%25.19M	-37.17%33.97M	180.55%119.39M	181.41%146.69M	208.13%89.43M
Other current liabilities	27.91%1.25M	37.66%1M	28.51%1.43M	-55.81%9.57M	-82.32%976.08K	-86.82%727.57K	-85.49%1.11M	28.92%21.66M	--5.52M	2,502.13%5.52M
Total current liabilities	11.21%595.82M	42.95%644.53M	-10.21%664.93M	5.54%893.83M	-36.48%535.76M	-46.31%450.87M	-7.92%740.51M	2.14%846.94M	49.68%843.49M	75.65%839.78M
Current liabilities
Long term loan	23.10%199.46M	-44.85%107.86M	-54.36%98.63M	-42.26%73.92M	66.78%162.04M	10.91%195.58M	0.95%216.11M	-43.58%128.03M	-57.29%97.16M	-31.65%176.34M
Estimate liabilities	--1.34M	--1.34M	--1.34M	--1.34M	----	----	----	----	----	----
Deferred tax liabilities	----	----	----	----	-93.47%46.76K	-93.47%46.76K	-93.72%46.05K	-54.90%330.64K	24.35%716.17K	24.35%716.17K
Long term deferred income	-6.21%78.65M	-17.62%74.38M	-5.85%86.8M	-9.00%89.04M	-14.02%83.85M	-12.03%90.29M	-15.43%92.2M	-12.03%97.85M	-20.95%97.53M	-4.84%102.65M
Lease liabilities	-37.89%44.9M	-35.54%47.21M	-41.53%46.9M	-22.31%60.95M	-6.04%72.29M	-5.88%73.24M	-7.46%80.21M	-10.78%78.45M	-9.45%76.94M	-9.37%77.81M
Total non current liabilities	1.92%324.34M	-35.74%230.79M	-39.86%233.67M	-26.06%225.25M	16.85%318.23M	0.46%359.16M	-5.35%388.57M	-28.62%304.66M	-37.59%272.34M	-20.96%357.51M
Total liabilities	7.75%920.16M	8.06%875.31M	-20.41%898.6M	-2.82%1.12B	-23.47%853.98M	-32.35%810.02M	-7.05%1.13B	-8.32%1.15B	11.59%1.12B	28.68%1.2B
Shareholders equity
Paid-in capital	0.00%587.57M	0.00%587.57M	0.00%587.57M	0.00%587.57M	0.00%587.57M	-0.45%587.57M	-0.45%587.57M	-0.45%587.57M	-0.45%587.57M	0.00%590.2M
Capital reserve funds	1.37%672.09M	2.34%672.09M	2.87%669.24M	4.77%669.24M	6.93%662.99M	3.49%656.75M	5.57%650.57M	-7.46%638.76M	-10.17%620.03M	-8.07%634.58M
Surplus reserve funds	0.00%325.5M	0.00%325.5M	0.00%325.5M	0.00%325.5M	0.00%325.5M	0.00%325.5M	0.00%325.5M	0.00%325.5M	0.00%325.5M	0.00%325.5M
Retained profit	3.96%1.47B	-0.70%1.38B	-4.18%1.36B	0.80%1.26B	-4.28%1.41B	-4.06%1.39B	-9.18%1.42B	-13.48%1.25B	-9.17%1.47B	-7.90%1.45B
Less:Treasury stock	----	----	----	----	----	----	----	----	-58.77%84.1M	-41.17%120.02M
Other composite income	-221.62%-36.04M	-814.21%-34.56M	-362.31%-31.99M	-260.71%-22.72M	-221.92%-11.21M	118.59%4.84M	382.04%12.19M	469.18%14.13M	595.78%9.19M	195.86%2.21M
Shareholders equity without minority interests	1.35%3.01B	-1.14%2.93B	-2.83%2.91B	0.13%2.82B	1.49%2.97B	2.89%2.97B	0.85%2.99B	-0.93%2.81B	-3.00%2.93B	-3.08%2.88B
Total shareholder equity	1.35%3.01B	-1.14%2.93B	-2.83%2.91B	0.13%2.82B	1.49%2.97B	2.89%2.97B	0.85%2.99B	-0.93%2.81B	-3.00%2.93B	-3.08%2.88B
Total liabilityies and equity	2.77%3.93B	0.83%3.81B	-7.65%3.81B	-0.73%3.94B	-5.39%3.83B	-7.45%3.78B	-1.45%4.12B	-3.20%3.96B	0.63%4.05B	4.49%4.08B
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--	--	Tianjian Certified Public Accountants (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

002275 Guilin Sanjin Pharmaceutical

Guilin Sanjin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target